Cargando…
Rapamycin inhibits hepatitis B virus covalently closed circular DNA transcription by enhancing the ubiquitination of HBx
Hepatitis B virus (HBV) infection is still a serious public health problem worldwide. Antiviral therapies such as interferon and nucleos(t)ide analogs efficiently control HBV replication, but they cannot eradicate chronic hepatitis B (CHB) because of their incapacity to eliminate endocellular covale...
Autores principales: | Zhang, Yuan, Li, Liang, Cheng, Sheng-Tao, Qin, Yi-Ping, He, Xin, Li, Fan, Wu, Dai-Qing, Ren, Fang, Yu, Hai-Bo, Liu, Jing, Chen, Juan, Ren, Ji-Hua, Zhang, Zhen-Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403416/ https://www.ncbi.nlm.nih.gov/pubmed/36033851 http://dx.doi.org/10.3389/fmicb.2022.850087 |
Ejemplares similares
-
Nonproductive Hepatitis B Virus Covalently Closed Circular DNA Generates HBx-Related Transcripts from the HBx/Enhancer I Region and Acquires Reactivation by Superinfection in Single Cells
por: Peng, Bo, et al.
Publicado: (2022) -
CRISPR/Cas13-assisted hepatitis B virus covalently closed circular DNA detection
por: Zhang, Xiangying, et al.
Publicado: (2022) -
Approaches to quantifying hepatitis B virus covalently closed circular DNA
por: Zhang, Henrik, et al.
Publicado: (2022) -
Research progress in hepatitis B virus covalently closed circular DNA
por: Zhang, Xiaodong, et al.
Publicado: (2022) -
Detection of HBV Covalently Closed Circular DNA
por: Li, Xiaoling, et al.
Publicado: (2017)